Company Overview
About McKesson
McKesson Corporation is the largest pharmaceutical distributor in North America and a leading healthcare services company, founded in 1833 in New York City by John McKesson and Charles Olcott and now headquartered in Irving, Texas, trading on NYSE (MCK). The company reported approximately $308.9 billion in revenues for fiscal year 2024 (ending March 31, 2024) under CEO Brian Tyler, making it one of the highest-revenue companies in the United States—though the vast majority of revenues represent pass-through pharmaceutical product costs distributed to approximately 40,000 pharmacies, health systems, and medical providers across North America. McKesson operates through four segments: U.S. Pharmaceutical (the dominant distribution engine), Prescription Technology Solutions (pharmacy benefits technology including CoverMyMeds e-prior authorization), Medical-Surgical Solutions (physician office and extended care medical supply distribution), and International (primarily Canadian distribution through McKesson Canada).
Business Model & Competitive Advantage
McKesson's pharmaceutical distribution business generates thin but highly predictable gross margins—typically 2-4% of revenues—on the enormous volume of branded and generic pharmaceuticals flowing from manufacturers to dispensing points. The company earns fee-for-service and price appreciation income in addition to distribution margin, particularly from branded pharmaceuticals where manufacturer price increases translate into inventory holding gains. The specialty pharmaceutical distribution segment—particularly oncology drugs distributed through McKesson's US Oncology Network (a physician services organization supporting over 1,700 oncologists)—commands higher margins than standard pharmaceutical distribution and provides access to high-cost specialty drugs that require specialized handling, reimbursement support, and clinical expertise.
Competitive Landscape 2025–2026
In 2025-2026, McKesson competes with Cencora (formerly AmerisourceBergen, ABC) and Cardinal Health (CAH) in the pharmaceutical distribution triopoly that collectively handles approximately 90% of U.S. pharmaceutical distribution. This oligopolistic structure provides pricing stability and durable margins absent competitive disruption. The three distributors' partial responsibility (as wholesalers) for the U.S. opioid epidemic resulted in a combined $21 billion settlement in 2022—McKesson's share approximately $8.2 billion payable over 18 years—creating a significant financial obligation that is being funded from ongoing free cash flow. McKesson's increasing focus on oncology—through US Oncology Network expansion, specialty drug distribution growth, and oncology software platforms—addresses the highest-growth and highest-margin segment within pharmaceutical distribution.
The McKesson Story
Founders
Company Timeline
Major milestones in McKesson's journey
Leadership Team
Meet the leaders behind McKesson
Brian S. Tyler, Ph.D.
Brian Tyler has served as CEO of McKesson Corporation since April 2019 and previously served as President and Chief Operating Officer from August 2018 to March 2019. With more than 25 years at McKesson, Tyler has held wide-ranging leadership roles across McKesson Europe, North American Pharmaceutical Distribution Services, Corporate Strategy and Business Development, and other divisions, bringing comprehensive company knowledge and strategic vision to the CEO role.
Leann Smith
Leann Smith leads McKesson's global human resources strategy, overseeing talent acquisition, employee development, compensation and benefits, diversity and inclusion initiatives, and organizational culture across the company's 80,000+ employee base spanning North America and international operations.
Tom Rodgers
Tom Rodgers is responsible for McKesson's corporate strategy development, mergers and acquisitions execution, strategic partnerships, and long-term business planning. He has played a key role in major strategic transactions including the Core Ventures, PRISM Vision Holdings, and Compile acquisitions that have strengthened McKesson's specialty healthcare platform.
Dr. Kelvin Baggett
Dr. Kelvin Baggett leads McKesson's global strategy and execution of environmental, social, and governance (ESG) positions, sustainability and environmental practices, diversity, equity and inclusion (DEI) initiatives, McKesson Foundation philanthropy, and corporate social responsibility programs, positioning the company as a responsible corporate citizen.
Open Positions
Reddit Discussions
Key Differentiators
Market Leader
McKesson is recognized as a market leader in the Healthcare sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $308900M in revenue, McKesson operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
Yoneda Labs
Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit
Decoda Health
Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap
Fortuna Health
Fortuna Health is a New York City-based healthcare technology company — backed by Y Combinator with $22 million in total funding including an $18 million Series A in July 2025 led by Andreessen Horowi
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp
Compare McKesson with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from McKesson? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim McKesson Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention McKesson vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →